TipRanks
Advertisement
Advertisement

DE:ZA71 Stock Latest News

Larimar Therapeutics Appoints New President and COO
Company AnnouncementsLarimar Therapeutics Appoints New President and COO
12d ago
8K
LRMR
Larimar Therapeutics appoints John Harlow as COO
PremiumThe Fly
Larimar Therapeutics appoints John Harlow as COO
12d ago
LRMR
Larimar Therapeutics assumed with an Outperform at Leerink
PremiumThe Fly
Larimar Therapeutics assumed with an Outperform at Leerink
27d ago
LRMR
Larimar Therapeutics price target lowered to $11 from $12 at Wedbush
PremiumThe Fly
Larimar Therapeutics price target lowered to $11 from $12 at Wedbush
2M ago
LRMR
Larimar Therapeutics: Buy Rating Reaffirmed as FDA-Backed Nomlabofusp Progress Supports Unchanged $25 Price Target
PremiumRatings
Larimar Therapeutics: Buy Rating Reaffirmed as FDA-Backed Nomlabofusp Progress Supports Unchanged $25 Price Target
2M ago
LRMR
Analyst Sees Larimar as Undervalued on Nomlabofusp’s Strong Efficacy and On‑Track BLA, Reiterates Buy Rating Ahead of 2027 FA Launch
PremiumRatingsAnalyst Sees Larimar as Undervalued on Nomlabofusp’s Strong Efficacy and On‑Track BLA, Reiterates Buy Rating Ahead of 2027 FA Launch
2M ago
LRMR
Regulatory and Manufacturing Risks Cloud Larimar Therapeutics’ Accelerated Approval Path for Nomlabofusp
Premium
Company Announcements
Regulatory and Manufacturing Risks Cloud Larimar Therapeutics’ Accelerated Approval Path for Nomlabofusp
2M ago
LRMR
Larimar Therapeutics reports Q2 EPS (30c), consensus (38c)
Premium
The Fly
Larimar Therapeutics reports Q2 EPS (30c), consensus (38c)
2M ago
LRMR
Larimar reports Q2 results and nomlabofusp progress
PremiumCompany Announcements
Larimar reports Q2 results and nomlabofusp progress
2M ago
8K
LRMR
Larimar Therapeutics, Inc. (LRMR) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Larimar Therapeutics, Inc. (LRMR) Q2 Earnings Cheat Sheet
2M ago
LRMR
Buy Rating Reaffirmed on Growing Nomlabofusp Confidence; $25 Price Target Maintained
PremiumRatings
Buy Rating Reaffirmed on Growing Nomlabofusp Confidence; $25 Price Target Maintained
3M ago
LRMR
Closing Bell Movers: Levi Strauss down 6% on earnings
PremiumThe Fly
Closing Bell Movers: Levi Strauss down 6% on earnings
3M ago
AP
AZZ
Larimar Therapeutics director buys $167K in common stock
PremiumThe FlyLarimar Therapeutics director buys $167K in common stock
3M ago
LRMR
Citizens biotech analysts hold an analyst/industry conference call
Premium
The Fly
Citizens biotech analysts hold an analyst/industry conference call
3M ago
BIIB
DSGN
Larimar Therapeutics assumed with a Buy at H.C. Wainwright
Premium
The Fly
Larimar Therapeutics assumed with a Buy at H.C. Wainwright
3M ago
LRMR
Larimar Therapeutics price target lowered to $5 from $7 at Baird
PremiumThe Fly
Larimar Therapeutics price target lowered to $5 from $7 at Baird
3M ago
LRMR
Larimar Therapeutics selloff a buying opportunity, says Citi
PremiumThe Fly
Larimar Therapeutics selloff a buying opportunity, says Citi
3M ago
LRMR
Larimar Therapeutics: Buy Rating on Nomlabofusp’s Robust FA Efficacy and De-Risked Regulatory Pathway
PremiumRatings
Larimar Therapeutics: Buy Rating on Nomlabofusp’s Robust FA Efficacy and De-Risked Regulatory Pathway
3M ago
LRMR
Nomlabofusp Progress and Durable Efficacy Support Buy Rating on LRMR with Unchanged $25 Price Target
PremiumRatings
Nomlabofusp Progress and Durable Efficacy Support Buy Rating on LRMR with Unchanged $25 Price Target
3M ago
LRMR
Midday Fly By: SpaceX to join Nasdaq-100, Comcast to split into two companies
PremiumThe FlyMidday Fly By: SpaceX to join Nasdaq-100, Comcast to split into two companies
3M ago
VZ
CRM
Larimar stumbles on safety news even as BLA submission kicks off
Premium
The Fly
Larimar stumbles on safety news even as BLA submission kicks off
3M ago
LRMR
Larimar Advances Nomlabofusp BLA Toward Accelerated Approval
Premium
Company Announcements
Larimar Advances Nomlabofusp BLA Toward Accelerated Approval
3M ago
8K
LRMR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >